KTX-612 structure
|
Common Name | KTX-612 | ||
|---|---|---|---|---|
| CAS Number | 2573298-14-1 | Molecular Weight | 868.94 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C46H51F3N8O6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of KTX-612KTX-612 is an orally active IRAK4 degrader with a DC50 value of 7 nM. KTX-612 can be used for the research of oncology[1]. |
| Name | KTX-612 |
|---|
| Description | KTX-612 is an orally active IRAK4 degrader with a DC50 value of 7 nM. KTX-612 can be used for the research of oncology[1]. |
|---|---|
| Related Catalog | |
| Target |
IRAK4:7 nM (DC50) |
| In Vitro | KTX-612 has activity for IRAK4 with a DC50 value of 7 nM[1]. |
| In Vivo | KTX-612 (oral; 10 mg/kg) impacts oral absorption[1]. Animal Model: Rat[1] Dosage: 10 mg/kg Administration: Oral Result: Rat PO PK (10 mg/kg) KTX-612 %F 1 AUC(μM*hr) 0.060 |
| References |
| Molecular Formula | C46H51F3N8O6 |
|---|---|
| Molecular Weight | 868.94 |